경구 고형제 위탁생산 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for oral solid dosage contract manufacturing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global oral solid dosage contract manufacturing market from 2025 to 2032.

Key Insights:

• Oral Solid Dosage Contract Manufacturing Market Size (2025E): US$ 38 Bn
• Projected Market Value (2032F):US$ 57.9 Bn
• Global Market Growth Rate (CAGR 2025 to 2032): 6.2%

Oral Solid Dosage Contract Manufacturing Market - Report Scope:

Oral solid dosage forms, such as tablets, capsules, and soft gels, play a vital role in the pharmaceutical industry. The oral solid dosage contract manufacturing market offers outsourced production services to pharmaceutical companies that specialize in the development and production of these dosage forms. The market serves the needs of generic drug manufacturers, biotechnology companies, and contract research organizations (CROs), providing them with expertise in formulation development, regulatory compliance, and large-scale production. Market growth is driven by an increasing demand for oral solid dosage forms, the rising prevalence of chronic diseases, and the growing focus on cost-effective manufacturing solutions.

Market Growth Drivers:

The global oral solid dosage contract manufacturing market is propelled by several key factors, including the increasing adoption of outsourcing among pharmaceutical companies looking to reduce production costs and enhance operational efficiency. As the pharmaceutical industry faces growing pressure to meet the demands of a larger, aging population, the outsourcing of manufacturing allows companies to focus on their core competencies, such as research and development. Furthermore, the demand for generic drugs and biosimilars is expected to increase, further fueling the need for high-quality, cost-effective oral solid dosage manufacturing services. Additionally, advancements in manufacturing technologies, such as continuous manufacturing and advanced coating techniques, are improving the efficiency and quality of production processes, fostering market growth.

Market Restraints:

Despite the promising growth prospects, the oral solid dosage contract manufacturing market faces challenges related to regulatory compliance, intellectual property protection, and fluctuating raw material costs. Stringent regulatory requirements governing the manufacturing and approval of pharmaceutical products create significant barriers to entry for new market players and increase operational costs. Furthermore, issues related to intellectual property, such as the protection of proprietary formulations and technologies, present ongoing risks. In addition, rising raw material prices and supply chain disruptions can impact the profitability of contract manufacturers, particularly in developing regions where resources may be limited.

Market Opportunities:

The oral solid dosage contract manufacturing market presents significant growth opportunities driven by the increasing demand for high-quality, affordable medicines and the ongoing shift toward outsourcing in the pharmaceutical industry. With the rise in chronic diseases and the aging population, there is an expanding market for generic drugs, creating a need for reliable contract manufacturing services. Moreover, advancements in personalized medicine and the development of new drug formulations offer opportunities for contract manufacturers to innovate and cater to evolving market needs. Strategic partnerships, investments in state-of-the-art facilities, and the expansion of services in emerging markets will be key drivers of future growth.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the oral solid dosage contract manufacturing market globally?
• How are outsourcing trends influencing the competitive landscape of the market?
• What are the technological advancements that are reshaping oral solid dosage manufacturing?
• Who are the key players contributing to the oral solid dosage contract manufacturing market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global oral solid dosage contract manufacturing market?

Competitive Intelligence and Business Strategy:

Leading players in the global oral solid dosage contract manufacturing market, including Lonza Group, Catalent, Inc., and Samsung Biologics, focus on expanding their manufacturing capabilities and service offerings to meet the diverse needs of pharmaceutical companies. These companies invest in the development of state-of-the-art manufacturing facilities, enhancing their ability to produce a wide range of oral solid dosage forms, including tablets, capsules, and controlled-release formulations. Moreover, they are actively engaged in strategic partnerships, acquisitions, and collaborations with pharmaceutical companies and research institutions to enhance their market position and drive innovation.

Key Companies Profiled:

• Lonza Group
• Catalent, Inc.
• Samsung Biologics
• Patheon
• WuXi AppTec
• Recipharm
• Aenova Group
• Boehringer Ingelheim
• Siegfried Holding AG
• Piramal Pharma Solutions

Oral Solid Dosage Contract Manufacturing Market Segmentation

By Dosage Form

• Tablets
• Capsules
• Capsules/Softgels
• Powders & Granules
• Lozenges & Pastilles
• Gummies

By Mechanism

• Immediate Release
• Delayed Release
• Controlled Release

By Application

• Drug Product Development
• Fill & Finish Product Manufacturing
• Packaging /Labelling

By End User

• Big Pharma/Biotech Companies
• Smalls & Medium-size Pharma/Biotech Companies
• Emerging/virtual Pharma Companies
• Nutraceutical Companies

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Middle East and Africa
• Latin America

Table of Contents

1. Executive Summary

• 1.1. Global Oral Solid Dosage Contract Manufacturing Market Snapshot, 2025-2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Regulatory Landscape
• 3.2. Product Adoption Analysis
• 3.3. Value Chain Analysis
• 3.4. Key Deals and Mergers
• 3.5. PESTLE Analysis
• 3.6. Porter's Five Force Analysis

4. Global Oral Solid Dosage Contract Manufacturing Market Outlook:

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Bn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
  • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
• 4.3. Global Oral Solid Dosage Contract Manufacturing Market Outlook: Dosage Form
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Dosage Form, 2019-2024
  • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Dosage Form, 2025-2032
    • 4.3.3.1. Tablets
      • 4.3.3.1.1. Conventional Release
      • 4.3.3.1.2. Modified Release
      • 4.3.3.1.3. Chewable Tablets
      • 4.3.3.1.4. Effervescent Tablets
    • 4.3.3.2. Capsules
      • 4.3.3.2.1. Hard Gelatin Capsules
      • 4.3.3.2.2. Soft Gelatin
    • 4.3.3.3. Capsules/Softgels
    • 4.3.3.4. Powders & Granules
    • 4.3.3.5. Lozenges & Pastilles
    • 4.3.3.6. Gummies
  • 4.3.4. Market Attractiveness Analysis: Dosage Form
• 4.4. Global Oral Solid Dosage Contract Manufacturing Market Outlook: Mechanism
  • 4.4.1. Introduction / Key Findings
  • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Mechanism, 2019-2024
  • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025-2032
    • 4.4.3.1. Immediate Release
    • 4.4.3.2. Delayed Release
    • 4.4.3.3. Controlled Release
  • 4.4.4. Market Attractiveness Analysis: Mechanism
• 4.5. Global Oral Solid Dosage Contract Manufacturing Market Outlook: Application
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
  • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 4.5.3.1. Drug Product Development
    • 4.5.3.2. Fill & Finish Product Manufacturing
    • 4.5.3.3. Packaging /Labelling
    • 4.5.3.4. Others
  • 4.5.4. Market Attractiveness Analysis: Application
• 4.6. Global Oral Solid Dosage Contract Manufacturing Market Outlook: End User
  • 4.6.1. Introduction / Key Findings
  • 4.6.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2024
  • 4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 4.6.3.1. Big Pharma/Biotech Companies
    • 4.6.3.2. Smalls & Medium-size Pharma/Biotech Companies
    • 4.6.3.3. Emerging/virtual Pharma Companies
    • 4.6.3.4. Nutraceutical Companies
  • 4.6.4. Market Attractiveness Analysis: End User

5. Global Oral Solid Dosage Contract Manufacturing Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
• 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Oral Solid Dosage Contract Manufacturing Market Outlook:

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 6.2.1. By Country
  • 6.2.2. By Dosage Form
  • 6.2.3. By Mechanism
  • 6.2.4. By Application
  • 6.2.5. By End User
• 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Dosage Form, 2025-2032
  • 6.4.1. Tablets
  • 6.4.2. Capsules
  • 6.4.3. Capsules/Softgels
  • 6.4.4. Powders & Granules
  • 6.4.5. Lozenges & Pastilles
  • 6.4.6. Gummies
• 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025-2032
  • 6.5.1. Immediate Release
  • 6.5.2. Delayed Release
  • 6.5.3. Controlled Release
• 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 6.6.1. Drug Product Development
  • 6.6.2. Fill & Finish Product Manufacturing
  • 6.6.3. Packaging /Labelling
  • 6.6.4. Others
• 6.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 6.7.1. Big Pharma/Biotech Companies
  • 6.7.2. Smalls & Medium-size Pharma/Biotech Companies
  • 6.7.3. Emerging/virtual Pharma Companies
  • 6.7.4. Nutraceutical Companies
• 6.8. Market Attractiveness Analysis

7. Europe Oral Solid Dosage Contract Manufacturing Market Outlook:

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Dosage Form
  • 7.2.3. By Mechanism
  • 7.2.4. By Application
  • 7.2.5. By End User
• 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkey
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Dosage Form, 2025-2032
  • 7.4.1. Tablets
  • 7.4.2. Capsules
  • 7.4.3. Capsules/Softgels
  • 7.4.4. Powders & Granules
  • 7.4.5. Lozenges & Pastilles
  • 7.4.6. Gummies
• 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025-2032
  • 7.5.1. Immediate Release
  • 7.5.2. Delayed Release
  • 7.5.3. Controlled Release
• 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 7.6.1. Drug Product Development
  • 7.6.2. Fill & Finish Product Manufacturing
  • 7.6.3. Packaging /Labelling
  • 7.6.4. Others
• 7.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 7.7.1. Big Pharma/Biotech Companies
  • 7.7.2. Smalls & Medium-size Pharma/Biotech Companies
  • 7.7.3. Emerging/virtual Pharma Companies
  • 7.7.4. Nutraceutical Companies
• 7.8. Market Attractiveness Analysis

8. East Asia Oral Solid Dosage Contract Manufacturing Market Outlook:

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Dosage Form
  • 8.2.3. By Mechanism
  • 8.2.4. By Application
  • 8.2.5. By End User
• 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Dosage Form, 2025-2032
  • 8.4.1. Tablets
  • 8.4.2. Capsules
  • 8.4.3. Capsules/Softgels
  • 8.4.4. Powders & Granules
  • 8.4.5. Lozenges & Pastilles
  • 8.4.6. Gummies
• 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025-2032
  • 8.5.1. Immediate Release
  • 8.5.2. Delayed Release
  • 8.5.3. Controlled Release
• 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 8.6.1. Drug Product Development
  • 8.6.2. Fill & Finish Product Manufacturing
  • 8.6.3. Packaging /Labelling
  • 8.6.4. Others
• 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 8.7.1. Big Pharma/Biotech Companies
  • 8.7.2. Smalls & Medium-size Pharma/Biotech Companies
  • 8.7.3. Emerging/virtual Pharma Companies
  • 8.7.4. Nutraceutical Companies
• 8.8. Market Attractiveness Analysis

9. South Asia & Oceania Oral Solid Dosage Contract Manufacturing Market Outlook:

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Dosage Form
  • 9.2.3. By Mechanism
  • 9.2.4. By Application
  • 9.2.5. By End User
• 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Dosage Form, 2025-2032
  • 9.4.1. Tablets
  • 9.4.2. Capsules
  • 9.4.3. Capsules/Softgels
  • 9.4.4. Powders & Granules
  • 9.4.5. Lozenges & Pastilles
  • 9.4.6. Gummies
• 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025-2032
  • 9.5.1. Immediate Release
  • 9.5.2. Delayed Release
  • 9.5.3. Controlled Release
• 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 9.6.1. Drug Product Development
  • 9.6.2. Fill & Finish Product Manufacturing
  • 9.6.3. Packaging /Labelling
  • 9.6.4. Others
• 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 9.7.1. Big Pharma/Biotech Companies
  • 9.7.2. Smalls & Medium-size Pharma/Biotech Companies
  • 9.7.3. Emerging/virtual Pharma Companies
  • 9.7.4. Nutraceutical Companies
• 9.8. Market Attractiveness Analysis

10. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook:

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Dosage Form
  • 10.2.3. By Mechanism
  • 10.2.4. By Application
  • 10.2.5. By End User
• 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Dosage Form, 2025-2032
  • 10.4.1. Tablets
  • 10.4.2. Capsules
  • 10.4.3. Capsules/Softgels
  • 10.4.4. Powders & Granules
  • 10.4.5. Lozenges & Pastilles
  • 10.4.6. Gummies
• 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025-2032
  • 10.5.1. Immediate Release
  • 10.5.2. Delayed Release
  • 10.5.3. Controlled Release
• 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 10.6.1. Drug Product Development
  • 10.6.2. Fill & Finish Product Manufacturing
  • 10.6.3. Packaging /Labelling
  • 10.6.4. Others
• 10.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 10.7.1. Big Pharma/Biotech Companies
  • 10.7.2. Smalls & Medium-size Pharma/Biotech Companies
  • 10.7.3. Emerging/virtual Pharma Companies
  • 10.7.4. Nutraceutical Companies
• 10.8. Market Attractiveness Analysis

11. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook:

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Dosage Form
  • 11.2.3. By Mechanism
  • 11.2.4. By Application
  • 11.2.5. By End User
• 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Dosage Form, 2025-2032
  • 11.4.1. Tablets
  • 11.4.2. Capsules
  • 11.4.3. Capsules/Softgels
  • 11.4.4. Powders & Granules
  • 11.4.5. Lozenges & Pastilles
  • 11.4.6. Gummies
• 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025-2032
  • 11.5.1. Immediate Release
  • 11.5.2. Delayed Release
  • 11.5.3. Controlled Release
• 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 11.6.1. Drug Product Development
  • 11.6.2. Fill & Finish Product Manufacturing
  • 11.6.3. Packaging /Labelling
  • 11.6.4. Others
• 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 11.7.1. Big Pharma/Biotech Companies
  • 11.7.2. Smalls & Medium-size Pharma/Biotech Companies
  • 11.7.3. Emerging/virtual Pharma Companies
  • 11.7.4. Nutraceutical Companies
• 11.8. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2025
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Recipharm
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Dosage Forms
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. Aenova Holding
  • 12.3.3. Catalent
  • 12.3.4. AbbVie
  • 12.3.5. Patheon N.V. (Thermo Fisher Scientific)
  • 12.3.6. NextPharma
  • 12.3.7. Lonza Group AG
  • 12.3.8. Merck KGaA
  • 12.3.9. Aurobindo Pharma Limited
  • 12.3.10. Siegfried AG
  • 12.3.11. Piramal Pharma Solutions
  • 12.3.12. Corden Pharma
  • 12.3.13. HERMES PHARMA GmbH
  • 12.3.14. Medipaams India Private Limited
  • 12.3.15. Alpex Pharma
  • 12.3.16. Abaris Healthcare Pvt Ltd
  • 12.3.17. Ardena Holdings N.V
  • 12.3.18. Aphena Pharma Solutions
  • 12.3.19. Actiza Pharmaceutical Private Limited
  • 12.3.20. Sunwin Healthcare PVT. LTD
  • 12.3.21. Kosher Pharmaceuticals
  • 12.3.22. Boehringer Ingelheim BioXcellence

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations